# Korro Bio, Inc.: Form 8-K, filed Jun 6, 2023

- Company: [Korro Bio, Inc.](/companies/krro.md) (CIK 1703647)
- Form: 8-K
- Filed: 2023-06-06
- Accepted by EDGAR: Jun 6, 2023, 16:05 ET
- Period: 2023-05-31
- Accession: 0001193125-23-161600
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703647/000119312523161600/d390817d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703647/000119312523161600/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703647/000119312523161600/d390817d8k.htm

Filed Jun 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-161600. Last ingested by Listed: Nov 14, 2026, 23:34 ET. No prices; not investment advice.
